Close Menu

NEW YORK (GenomeWeb) -- Quest Diagnostics today reported that its second quarter revenues were up 1 percent year over year, meeting analysts' consensus estimate.

Quest's revenues for the three months ended June 30 were $1.93 billion compared to $1.90 billion for the second quarter in 2014. The top-line figure matched Wall Street's expectation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.